Ozempic Injection, Solution
Product Images NDC 50090-8027

Product Visual Gallery

This gallery contains 100 technical images submitted to the FDA as part of the official labeling for Ozempic (NDC 50090-8027). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ifu Mpfs After Use (2. Ifu Mpfs After Use.jpg)

An instructional diagram showing a syringe labeled with 'After use,' indicating the plunger is fully depressed and the injection is complete. The syringe design is consistent with subcutaneous injection devices like Ozempic (semaglutide) 0.68 mg/mL solution.*

FDA Label Image

Ifu Mpfs Before Use (Before After)

An instructional illustration showing a pre-use syringe for injection. The syringe parts are labeled, including the needle cap, label on the glass barrel containing medicine, plunger, and plunger rod. The image is likely for a subcutaneous injection solution product such as Ozempic semaglutide.*

FDA Label Image

Figure_6 (Figure 6)

A line graph showing the percentage of patients with an event over time from randomization in weeks for Ozempic (semaglutide) injection, solution 0.68 mg/mL versus placebo. The graph shows fewer events in the Ozempic group compared to placebo up to 109 weeks. Below the graph is a table of patients at risk for both groups at different weeks. The graph includes a hazard ratio (HR) of 0.74 with a 95% confidence interval (CI) of 0.58 to 0.95.*

FDA Label Image

Figure_7 (Figure 7)

A Kaplan-Meier curve showing percentage of patients with events over time from randomization in months, comparing Ozempic (semaglutide) and placebo groups. The graph includes hazard ratio (HR: 0.76) with 95% confidence interval (0.66-0.88). Below the graph, patient counts at risk are listed over intervals for both Ozempic and placebo groups.*

FDA Label Image

Figure_8 (Figure 8)

A Kaplan-Meier curve chart showing the percentage of patients with an event over time in months from randomization, comparing Ozempic and placebo groups. The chart includes patient counts at risk below the x-axis and a hazard ratio with 95% confidence interval in the chart area.*

FDA Label Image

Figure_9 (Figure 9)

A line graph comparing eGFR (mL/min/1.73m2) over time since randomisation (weeks) between Ozempic and placebo groups. The graph shows two curves with error bars: Ozempic in dark blue squares and placebo in gray triangles, with patient numbers listed below for each time point up to 104 weeks.*

FDA Label Image

Structural_formula (Image 01)

Chemical structure diagram of semaglutide, the active ingredient in Ozempic 0.68 mg/mL injection. The diagram depicts the molecular representation with amino acid sequences and chemical bonds relevant to the peptide structure.*

FDA Label Image

Figure 1. Mean 24-hour Plasma Glucose Profiles (Image 02)

This line graph displays plasma glucose levels (mg/dL) over 24 hours following the start of a breakfast meal, comparing Ozempic 1 mg treatment to placebo. It includes baseline and end-of-treatment data for each group, illustrating changes in glucose concentration over time with time in hours on the x-axis and glucose levels on the y-axis.*

FDA Label Image

Figure 2. Mean Insulin Secretion (Image 03)

A line chart comparing insulin secretion rate (pmol/kg/min) against plasma glucose levels (mg/dL) among four groups: OZEMPIC baseline, OZEMPIC 1 mg end of treatment, placebo baseline, placebo end of treatment, and healthy subjects. The chart shows increasing insulin secretion rates with plasma glucose, with OZEMPIC 1 mg and healthy subjects having higher rates than placebo groups.*

FDA Label Image

Figure_3 (Image 04)

A horizontal dot plot chart showing relative exposure (Cavg) ratios with 90% confidence intervals for the drug semaglutide by intrinsic factors including sex, age groups (65-74 years, >74 years), race (Black or African American, Asian), ethnicity (Hispanic or Latino), body weight (55 kg, 127 kg), and renal impairment severity (mild, moderate, severe). The chart compares these factors' effects on semaglutide exposure relative to a reference profile.*

FDA Label Image

Figure 4. Impact Of Semaglutid (Image 05)

A chart showing relative exposure ratios and 90% confidence intervals for several co-administered medications (Metformin, S-warfarin, R-warfarin, Digoxin, Atorvastatin, Ethinylestradiol, Levonorgestrel) with a vertical reference line at 1. The chart plots AUC and Cmax values for each medication, all accompanied by recommendations of 'No dose adjustment.'*

FDA Label Image

Image_61 (Image 06)

Ozempic 0.68 mg/mL injection solution for subcutaneous use, presented in a blister pack containing four prefilled pens. The carton label shows the brand name Ozempic, the active ingredient semaglutide, strength, and the A-S Medication Solutions labeler information.*

FDA Label Image

Image_121 (Image 07)

The image shows a purple and white carton for Ozempic 0.68 mg/mL injection solution. The label includes the proprietary name Ozempic, active ingredient semaglutide, and indicates the product is for subcutaneous use. It is labeled with the manufacturer A-S Medication Solutions and NDC 50090-8027.*

FDA Label Image

Ozempic Pen And Parts (Image 08)

An illustrated labeled diagram of an Ozempic injection pen and needle components. It shows the pen cap, pen window, expiration date on the back of the pen label, dose counter, dose pointer, dose selector, and dose button on the pen. The needle components include an outer needle cap, inner needle cap, needle, and paper tab, all labeled clearly as example parts of the injection device.*

FDA Label Image

Image_123 (Image 09)

Instructional illustration showing how to twist or remove the cap from a pen device, likely for Ozempic (semaglutide) injection, solution. The diagram depicts hands gripping the pen and an arrow indicating the direction to turn the cap for removal.*

FDA Label Image

Image_124 (Image 10)

An illustration showing a close-up view of an injection pen device, likely for subcutaneous use, with a focus on the pen's mechanism and dosage window. The pen is positioned in a hand, demonstrating handling or use.*

FDA Label Image

Image_116 (Image 100)

Ozempic 0.68 mg/mL injection, solution in a single-dose pen labeled for subcutaneous use. The label features the product name, active ingredient semaglutide, strength, dosage form, and the labeler A-S Medication Solutions. It shows usage instructions illustrations with numbered steps on the side.*

FDA Label Image

Image_117 (Image 101)

Ozempic 0.68 mg/mL injection, solution in a single-dose pen cartridge. The label prominently features the brand name Ozempic and the active ingredient semaglutide. It is labeled for subcutaneous use and manufactured by A-S Medication Solutions. The packaging shows dosage and storage instructions, as well as lot number and expiration date fields.*

FDA Label Image

Step 4: Pull Off The Needle Cap (Image 102)

An instructional illustration showing two hands preparing a syringe. The right hand holds a syringe with a needle attached, and the left hand holds a cap being removed from the needle, indicating the step of removing the needle cap before injection.*

FDA Label Image

Step 5: Insert Your Prefilled Syringe (Image 103)

An instructional illustration depicting the administration of an injection at a 45-degree angle. The image shows a hand holding a syringe with the needle directed towards the skin on the arm, indicating the proper angle for subcutaneous injection.*

FDA Label Image

Image_118 (Image 104)

FDA Label Image

Image_119 (Image 105)

FDA Label Image

Step 6 Inject Your Dose (Image 106)

An illustration showing how to administer a subcutaneous injection using a syringe. The image depicts a hand holding the syringe and inserting the needle into the skin of an arm, with a close-up inset emphasizing the injection site and needle angle.*

FDA Label Image

Step 7 Remove Your Syringe (Image 107)

An instructional illustration showing a hand administering a subcutaneous injection at a 45-degree angle into the skin of the opposite arm. The image depicts proper needle angle technique for injection.*

FDA Label Image

Figure 5. Mean Hba1c (%) Over Time (Baseline to Week 56)

A line graph comparing the effect of Ozempic 0.5 mg, Ozempic 1 mg, and Sitagliptin on HbA1c (%) levels over 56 weeks post randomization. The graph shows HbA1c (%) on the y-axis and weeks on the x-axis, with separate lines representing each treatment group and numerical patient counts listed for several time points.*

FDA Label Image

Step 1 Take One Prefilled Syringe (Image 109)

An instructional illustration showing a hand holding a prefilled Ozempic injection pen for subcutaneous use. The image includes a black arrow pointing to the label area on the pen, highlighting the part where the medication information can be seen.*

FDA Label Image

Image_125 (Image 11)

An illustration showing hands holding a device with fingers positioned to turn or unlock a component, indicated by an arrow pointing left, suggesting an instruction on how to manipulate a part of the device used for subcutaneous injection.*

FDA Label Image

Ozempic Dose Counter Closeup (Image 110)

An instructional diagram showing two views of the Ozempic injection pen dose window. The image highlights a flow check symbol on the left and a dashed line on the right, which is used to guide the user in selecting their dose for the 0.68 mg/mL semaglutide subcutaneous injection by A-S Medication Solutions.*

FDA Label Image

Image 62 Ozempic Dose Counter (Image 111)

An instructional diagram showing a dosage selector button on an injection device. The diagram highlights a flow check symbol and a dashed line used as a guide to set the dose for the Ozempic 0.68 mg/mL subcutaneous injection.*

FDA Label Image

Image 92 Ozempic Dose Counter (Image 112)

An instructional diagram showing two labeled components: a 'Flow check symbol' and a 'Dashed line (used to guide to your dose).' These symbols appear to assist users in administering a dose correctly.*

FDA Label Image

Image_126 (Image 12)

An instructional illustration showing a close-up of a hand holding and preparing a prefilled injection pen, with fingers positioned near the needle cap. The image emphasizes how to properly grip and handle the injection device for subcutaneous use.*

FDA Label Image

Image_127 (Image 13)

An instructional illustration showing a hand holding a pen injector and removing or attaching a needle cap to the Ozempic 0.68 mg/mL subcutaneous injection pen. The image emphasizes proper handling and preparation of the injection device for semaglutide administration.*

FDA Label Image

Image_128 (Image 14)

An instructional illustration showing a hand removing a cap from the tip of a syringe or injection pen. An arrow indicates the direction to pull the cap away from the device, demonstrating preparation for subcutaneous injection.*

FDA Label Image

Image_129 (Image 15)

Ozempic 0.68 mg/mL injection, solution in a subcutaneous delivery form. The label shows the brand name Ozempic prominently, and the active ingredient semaglutide is mentioned. The manufacturer is A-S Medication Solutions. The container holds 2 mL of the solution, labeled as a prescription drug with storage instructions and other regulatory details evident on the label.*

FDA Label Image

Image_flow_check_5 (Image 16)

Ozempic 0.68 mg/mL injection, solution in a subcutaneous prefilled pen. The label shows the brand name Ozempic, active ingredient semaglutide, strength 0.68 mg/mL, and the labeler A-S Medication Solutions. The product NDC 50090-8027 is also visible.*

FDA Label Image

Image_130 (Image 17)

An instructional illustration showing hands holding an Ozempic injection pen for subcutaneous use. It highlights the 'Flow check symbol selected' with an arrow indicating the step, accompanied by a close-up inset of the symbol on the pen indicating 0.68 mg dose.*

FDA Label Image

Image_131 (Image 18)

An instructional illustration showing how to hold and operate an Ozempic injection pen. The image depicts a hand gripping the pen with an arrow indicating an upward motion, focusing on the pen's top part with a close-up view to show the activation or preparation step.*

FDA Label Image

Image_132 (Image 19)

Ozempic 0.68 mg/mL injection, solution in a pen device for subcutaneous use. The label shows the brand name Ozempic prominently with the active ingredient semaglutide noted. The labeler is A-S Medication Solutions. The pen is primarily white with purple and orange details, and includes dose information and instructions, intended for human prescription drug use.*

FDA Label Image

Image_dose_counter_5 (Image 20)

Ozempic 0.68 mg/mL injection solution label for subcutaneous use by A-S Medication Solutions. The label displays the product name, strength, dosage form, and labeler information. The packaging is primarily white with text and design elements in blue and purple tones. Includes a barcode and additional regulatory details.*

FDA Label Image

Image_133 (Image 21)

An instructional diagram showing a close-up of hands adjusting a dose selector on a pen injector. Below are visual examples of dashed lines corresponding to different selected doses, such as 0.25 mg and 0.5 mg, illustrating dose setting markings.*

FDA Label Image

Image_134 (Image 22)

The image shows the packaging label for Ozempic 0.68 mg/mL injection solution for subcutaneous use. The label includes the product name Ozempic, the active ingredient semaglutide, and strength 0.68 mg/mL. Labeler information is A-S Medication Solutions.*

FDA Label Image

Image_135 (Image 23)

An instructional illustration showing how to read the dose counter on a semaglutide injection pen labeled Ozempic. It depicts a close-up view of the dose counter indicating 0 mg with an arrow pointing to the counter, and an example below showing the counter stopped at 0.25 mg left, demonstrating dose measurement during use.*

FDA Label Image

Image_136 (Image 24)

An instructional illustration showing front and back views of a human torso with highlighted areas indicating recommended subcutaneous injection sites, including the abdomen, front thigh, and upper arm.*

FDA Label Image

Image_137 (Image 25)

An instructional illustration showing a hand holding an Ozempic injection pen. The illustration highlights a downward arrow indicating the pressing or pushing action to administer the injection subcutaneously.*

FDA Label Image

Image_138 (Image 26)

An instructional diagram showing a hand holding a prefilled injection pen for Ozempic (semaglutide) 0.68 mg/mL subcutaneous solution. An arrow indicates the direction to press the pen downwards for injection. A close-up inset highlights the dose window on the pen, displaying the selected dose.*

FDA Label Image

Image_139 (Image 27)

An instructional illustration showing a hand holding a pen-like injection device for subcutaneous use. A speech bubble instructs to count slowly "1-2-3-4-5-6," indicating the recommended timing for administering the injection, relevant for Ozempic (semaglutide) injection solution.*

FDA Label Image

Image_140 (Image 28)

Illustration showing an injection pen with an upward-pointing arrow, indicating a motion or step likely related to the use of an injectable solution device. The image focuses on the tip of the pen with the needle cover or cap visible.*

FDA Label Image

Image_141 (Image 29)

Ozempic 0.68 mg/mL injection solution in a 3 mL pre-filled pen cartridge with a label from A-S Medication Solutions. Label includes semaglutide as the active ingredient, subcutaneous route indication, and detailed usage instructions in small print. The label features a barcode, numeric and text dosage information, storage instructions, and manufacturer details.*

FDA Label Image

Image_142 (Image 30)

An instructional illustration showing a hand twisting the cap of a prefilled injection pen, likely demonstrating how to prepare the Ozempic (semaglutide) injection for use.*

FDA Label Image

Image_143 (Image 31)

An instructional illustration depicting a vial with a perforated top and a cap or stopper being pressed or pushed down into it, indicated by a downward arrow. The image likely demonstrates a step in preparing or accessing the medication for use.*

FDA Label Image

Image_144 (Image 32)

An instructional illustration showing hands removing or attaching a cap or component on a pen-like injection device, likely demonstrating preparation steps for subcutaneous injection.*

FDA Label Image

Image_145 (Image 33)

An instructional illustration depicting the removal of a cap from a pen injector device by pulling it away from the pen's body. The image uses arrows to indicate the direction of cap removal.*

FDA Label Image

Image_146 (Image 34)

The image shows the packaging label of Ozempic 0.68 mg/mL injection solution for subcutaneous use. The box features the proprietary name Ozempic prominently, with the generic name semaglutide below it. The label includes the A-S Medication Solutions logo and NDC 50090-8027, indicating the manufacturer and product code. The packaging is predominantly white and purple with distinct orange and blue striping.*

FDA Label Image

Image_147 (Image 35)

Ozempic 0.68 mg/mL injection solution in a pen injector device. The image shows a transparent pen with a gray cap, a purple and white label with the brand name and dosage strength visible, and a dosage scale window. The labeler is A-S Medication Solutions.*

FDA Label Image

Image_148 (Image 36)

FDA Label Image

Image_149 (Image 37)

FDA Label Image

Image 62 Ozempic Pen (Image 38)

An instructional illustration of the Ozempic pen and needle assembly components. It shows parts labeled including pen cap, pen window, expiration date, dose counter, dose pointer, dose selector, dose button, outer and inner needle caps, needle, and paper tab. This diagram visually identifies key elements of the Ozempic 0.68 mg/mL subcutaneous injection pen device.*

FDA Label Image

Image_63 (Image 39)

An instructional illustration labeled 'A' showing hands removing a protective cap from an Ozempic (semaglutide) injection pen. The image depicts the initial step for preparing the subcutaneous injection solution for use.*

FDA Label Image

Image_64 (Image 40)

Illustration showing a close-up of a hand holding a prefilled Ozempic (semaglutide) injection pen. The pen is visible with a transparent portion displaying the solution inside. The image focuses on proper handling of the injection device for subcutaneous administration.*

FDA Label Image

Image_65 (Image 41)

An instructional illustration showing hands removing a cap from a pen-style injector device, indicating preparation for injection.*

FDA Label Image

Image_66 (Image 42)

An instructional illustration showing a hand twisting the cap off the pen injector of Ozempic (.68 mg/mL solution for injection). The image demonstrates how to prepare the injection device for use by removing its protective cap.*

FDA Label Image

Image_67 (Image 43)

Instructional illustration showing a hand removing the cap from the tip of an injection pen, likely representing a step in using the Ozempic (semaglutide) injection solution pen for subcutaneous administration.*

FDA Label Image

Image_68 (Image 44)

An instructional illustration shows a hand removing the cap from the needle of a pen-style injection device, indicated by an arrow pointing away from the pen. This likely demonstrates a step in preparing a subcutaneous injection.*

FDA Label Image

Image_69 (Image 45)

The image shows the Ozempic 0.68 mg/mL injectable solution packaging label for subcutaneous use. The label features the product name Ozempic prominently, with the active ingredient semaglutide noted. The labeler is A-S Medication Solutions, and the package includes NDC 50090-8027. The label design includes color accents in orange and blue.*

FDA Label Image

Image_flow_check_3 (Image 46)

Ozempic 0.68 mg/mL injection solution in a cartridge, subcutaneous use, from A-S Medication Solutions. The image shows three cartridges containing the solution, arranged vertically inside a transparent plastic holder. The cartridges are labeled with the product name and strength.*

FDA Label Image

Image_70 (Image 47)

Instructional diagram showing how to perform a flow check on an Ozempic injection pen (semaglutide 0.68 mg/mL). It depicts two hands holding and twisting the pen's dose selector with an arrow indicating direction, highlighting the flow check symbol selection step for the subcutaneous injection device.*

FDA Label Image

Image_71 (Image 48)

An instructional illustration showing a hand holding a blue and clear injection pen, with a close-up inset of the pen's twistable cap. An upward arrow indicates the direction to twist or pull the cap off the pen, likely as a step in preparing the injection device for use.*

FDA Label Image

Image_72 (Image 49)

Ozempic 0.68 mg/mL injection solution for subcutaneous use in a pen injector device. The label shows product name, active ingredient semaglutide, strength, usage instructions, and manufacturer A-S Medication Solutions. The label includes dosage details and a syringe image indicating injection instructions.*

FDA Label Image

Iimage_dose_counter_3 (Image 50)

Ozempic 0.68 mg/mL injection solution in a prefilled pen is shown in the image. The label displays the brand name Ozempic and the generic name semaglutide. The product is for subcutaneous use, distributed by A-S Medication Solutions. The image includes dosing instructions and a prescription symbol, indicating its status as a human prescription drug.*

FDA Label Image

Image_73 (Image 51)

An instructional illustration showing a person adjusting a dose selector on a pen device for injection. The diagram highlights selecting a 1 mg dose by aligning the indicator with a dashed line, indicating dose selection for subcutaneous injection.*

FDA Label Image

Image_74 (Image 52)

Ozempic 0.68 mg/mL injection, solution in a single-dose prefilled pen by A-S Medication Solutions. The label includes dosage strength, route of administration as subcutaneous injection, and other regulatory information on a white and purple background.*

FDA Label Image

Image_75 (Image 53)

Illustration showing a dose counter on an injection device labeled with '0 mg' and '1 mg.' The image indicates that the dose counter has stopped, signaling 1 mg left, with an arrow suggesting rotation or adjustment of a part of the device. This likely relates to dose measurement or administration for a semaglutide injection.*

FDA Label Image

Image_76 (Image 54)

Illustration showing recommended subcutaneous injection sites for Ozempic (semaglutide) injection, solution .68 mg/mL. The diagram depicts the front and back of a human body with highlighted areas including the abdomen, front of the thighs, and upper buttocks as suitable injection locations.*

FDA Label Image

Image_77 (Image 55)

An instructional illustration showing a hand holding a pen-type injection device with an arrow pointing downward, indicating the action of pressing or injecting in a downward motion, likely related to the use of the Ozempic solution for subcutaneous injection.*

FDA Label Image

Image_78 (Image 56)

An instructional illustration shows a hand holding an injection pen labeled with a dosage window displaying '0 mg.' An arrow above the hand points downwards toward the injection site on the arm, indicating the method for administering a subcutaneous injection using the pen device.*

FDA Label Image

Image_79 (Image 57)

An instructional illustration showing a hand holding an injection pen, with a speech bubble instructing to count slowly from 1 to 6. The image demonstrates the proper technique or timing for using the pen injection device.*

FDA Label Image

Image_80 (Image 58)

An instructional diagram showing the correct way to hold an injection pen vertically with the needle pointing upward, indicated by a blue arrow above the pen. The image likely represents a step in preparing the Ozempic (semaglutide) 0.68 mg/mL subcutaneous injection for use.*

FDA Label Image

Image_81 (Image 59)

Ozempic 0.68 mg/mL injection, solution pen cartridge for subcutaneous use from A-S Medication Solutions. The image shows a single-dose reusable pen cartridge with labeling that includes the product name Ozempic and strength 0.68 mg/mL.*

FDA Label Image

Image_82 (Image 60)

An instructional diagram showing a hand twisting the cap off a prefilled injection pen, presumably for Ozempic (semaglutide) injection, solution, 0.68 mg/mL. The image highlights the step of removing the cap before use.*

FDA Label Image

Image_83 (Image 61)

An instructional illustration showing a dropper adding liquid into a sealed container with a starburst-shaped seal on top, indicating a step in preparing or using a medication injection.*

FDA Label Image

Image_84 (Image 62)

An instructional illustration showing hands holding a pen-like device with an arrow indicating a twisting motion, likely demonstrating how to prepare or adjust an Ozempic (semaglutide) subcutaneous injection pen for use.*

FDA Label Image

Image_85 (Image 63)

An instructional illustration showing the removal of a cap from a pen-style injection device. The image uses arrows to indicate pulling the cap directly away from the injection pen, likely indicating preparation steps before use.*

FDA Label Image

Image_86 (Image 64)

Ozempic 0.68 mg/mL injection solution label for subcutaneous use. The label shows a single-dose prefilled pen with the brand name Ozempic prominently displayed in purple and orange text. The active ingredient semaglutide is indicated on the label along with dosage form and strength. The labeler is A-S Medication Solutions, and the NDC 50090-8027 is visible.*

FDA Label Image

Image_87 (Image 65)

Ozempic 0.68 mg/mL injection solution label by A-S Medication Solutions. The label includes the proprietary name, generic name semaglutide, strength 0.68 mg/mL, route subcutaneous, drug type human prescription. The layout shows text information clearly on a white and blue background.*

FDA Label Image

Image_88 (Image 66)

FDA Label Image

Image_89 (Image 67)

FDA Label Image

Not Included In Your Carton (Image 68)

An instructional illustration depicting three items used in medication administration: an alcohol wipe, a cotton ball, and a sharps disposal container. Each item is labeled, showing tools for proper injection site preparation and safe needle disposal.*

FDA Label Image

Choose Your Injection Site (Image 71)

An instructional illustration showing recommended subcutaneous injection sites for Ozempic (semaglutide) injection. Highlighted areas include the stomach area, thighs, and the back of the upper arm (administered only with assistance). The inset image demonstrates an injection being administered into the stomach area.*

FDA Label Image

Image_91 (Image 73)

Ozempic 0.68 mg/mL injection solution label for subcutaneous use. The label shows the proprietary name Ozempic and active ingredient semaglutide. It includes dosing information and manufacturer details for A-S Medication Solutions. The label is white and green with blue and black text.*

FDA Label Image

Image 92 Ozempic Pen (Image 74)

An illustrated diagram showing the components of the Ozempic pen and needle. It labels the pen cap, pen window, expiration date area on the back, dose counter, dose pointer, dose selector, and dose button on the pen. It also shows the outer and inner needle caps, needle, and paper tab as separate components.*

FDA Label Image

Image_93 (Image 75)

An instructional diagram showing hands removing a cap from a pen-like injection device, indicating the first step for preparing the Ozempic (semaglutide) subcutaneous injection.*

FDA Label Image

Image_94 (Image 76)

Illustration showing the tip of a blue and white injection pen device, likely used for subcutaneous administration of medication. The image focuses on the needle area and part of the pen body, with no visible text or branding on the device itself.*

FDA Label Image

Image_95 (Image 77)

An instructional illustration showing a hand gripping a small cap or cover and pulling it off in the direction of an arrow, indicating the removal of the cap from a device or vial.*

FDA Label Image

Image_96 (Image 78)

An instructional illustration showing a hand gripping the cap of a pen-style injection device. The image suggests the action of removing or adjusting the cap on the device, which is likely associated with subcutaneous injection medication such as semaglutide.*

FDA Label Image

Image_97 (Image 79)

An instructional illustration showing a hand holding a cap and pulling it off the end of a pen injector device. A blue arrow indicates the direction of the cap removal away from the pen tip, likely demonstrating the step to prepare the injection device for use.*

FDA Label Image

Image_98 (Image 80)

An illustration showing a hand removing a protective cap from the needle of an injection pen device. The image likely instructs on preparing the Ozempic 0.68 mg/mL subcutaneous injection for use.*

FDA Label Image

Image_99 (Image 81)

Ozempic 0.68 mg/mL injection solution label. The label displays the product name Ozempic prominently along with the active ingredient semaglutide. It includes dosage form as injection, solution, and indicates the subcutaneous route of administration. The labeler is A-S Medication Solutions. The NDC number 50090-8027 is shown on the label.*

FDA Label Image

Image_flow_check_4 (Image 82)

Ozempic 0.68 mg/mL injection solution in a prefilled pen. The label shows the brand name Ozempic with the active ingredient semaglutide and strength, intended for subcutaneous use. The labeler is A-S Medication Solutions. The pen features dosage marks and administration instructions printed in blue and black text on a white background.*

FDA Label Image

Image_100 (Image 83)

An instructional illustration showing a hand holding an injection pen for Ozempic (semaglutide) 0.68 mg/mL solution for subcutaneous injection. The image highlights the selection of a 'flow check symbol' on the pen's dose display mechanism with an upward arrow indicating activation or adjustment.*

FDA Label Image

Image_101 (Image 84)

An instructional illustration showing a hand holding a pen injector device with a close-up inset of the device's top portion. The illustration includes an upward pointing arrow indicating the direction to pull or remove a cap or part from the pen injector. This likely represents a step in preparing or using a medication pen.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.